Exco InTouch Successfully Completes HIPAA Security Audit

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

20 January 2014 – Exco InTouch, the leading provider of patient engagement and data capture solutions for clinical research and healthcare providers, today announced that it has successfully undergone and completed an independent audit to assess compliance utilizing the National Institute of Standards and Technology (NIST) guidelines for Health Insurance Portability and Accountability Act (HIPAA) security.

HIPAA rules constitute a set of regulations from the US Department of Health & Human Services relating to any Protected Health Information (PHI) that identifies health or financial data of US citizens stored on computer systems. The Security Rule specifies a series of administrative, physical, and technical safeguards for covered entities and their business associates to use to assure the confidentiality, integrity, and availability of electronic PHI.

Dale Jessop, Chief Technology Officer at Exco InTouch commented “Security of data and the protection of personal information remain the highest priority for Exco InTouch. Whilst no formal certification for HIPAA exists, to be independently audited against NIST guidelines for HIPAA security provides further reassurance to our customers that Exco InTouch business operations are aligned to comply with HIPAA standards.”

Tim Davis, CEO and co-founder of Exco InTouch added “I am extremely proud of the team involved throughout the audit process, and also that of the 64 HIPAA citations we were audited on, no findings were reported”. As a result of this audit, Exco InTouch customers (for whom the company provides mobile and digital patient engagement solutions), can continue to be assured that their programs comply with these stringent security safeguards.

About Exco InTouch

Exco InTouch is leading provider of patient engagement and data capture solutions to support Clinical, Late Phase and mHealth programs for leading healthcare and biopharmaceutical companies. Placing the patient at its heart, our proven technology can be employed on any device, empowering the patient to be more involved in their healthcare and ultimately leading to better health outcomes. Using a combination of patented software and services our technology can be scaled up to match clients’ global requirements and our trusted, low risk applications mean that data is secure and protected, in line with global regulatory and data protection requirements.

Our solutions capitalize upon global mobile device and internet usage, using a device independent approach enabling involvement which integrates into daily life - resulting in motivated and compliant patients across a wealth of therapeutic, demographic and geographic programs in clinical and commercial settings. Since 2004, Exco InTouch have engaged with over 750,000 subjects across 85 countries, over 8000 hospitals and clinics, in 70 languages and 16 of the top 20 pharmaceutical companies have deployed our technology.

For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on +44 (0) 207 203 6740 or e-mail t.jervis@defacto.com.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC